In Vitro and In Vivo Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against CD33(+) Acute Myeloid Leukemia

Genetic engineering of T cells with chimeric T-cell receptors (CARs) is an attractive strategy to treat malignancies. It extends the range of antigens for adoptive T-cell immunotherapy, and major mechanisms of tumor escape are bypassed. With this strategy we redirected immune responses towards the C...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutour, A., Marin, V., Pizzitola, I., Valsesia-Wittmann, S., Lee, D., Yvon, E., Finney, H., Lawson, A., Brenner, M., Biondi, A., Biagi, E., Rousseau, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261457/
https://www.ncbi.nlm.nih.gov/pubmed/22272203
http://dx.doi.org/10.1155/2012/683065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261457/
https://www.ncbi.nlm.nih.gov/pubmed/22272203
http://dx.doi.org/10.1155/2012/683065

Ejemplares similares